C-Rad AB (CRAD B):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:C-Rad AB (CRAD B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7500
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, catalyst Tomo, catalyst PT, Cypra laser, and Gemini products. C-Rad’s senitel products provide a surface contour laser scanning system for patient positioning, monitoring and gating applications. The company’s Gemini product is a detector system used for tumor localization. It provides installation, application training, and aftersales services. The markets its products through a network of distributors in Sweden, Korea, India, Thailand, China, Taiwan, Poland, Belgium, the Netherlands, Spain, France, the UK, and others. C-Rad is headquartered in Uppsala, Sweden.

C-Rad AB (CRAD B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
C-Rad AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
C-Rad AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
C-Rad AB, Medical Equipment, Deal Details 10
Partnerships 10
GE Healthcare Enters into Distribution Agreement with C-Rad 10
Equity Offering 11
C-Rad Raises USD2.5 Million in Private Placement of Series B Shares 11
C-RAD Raises USD5.4 Million in Rights Offering of Shares 12
C-RAD to Raise USD3 Million in Rights Offering of Series B Shares 14
Acquisition 15
C-Rad Acquires Remaining 71% Stake in Cyrpa International 15
C-Rad Acquired 29% Stake In Cyrpa International, Radiotherapy Products Developer, For USD1.4 Million 17
C-Rad AB – Key Competitors 18
C-Rad AB – Key Employees 19
C-Rad AB – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 17, 2018: C-RAD – Interim report January-June 2018 21
Apr 26, 2018: C-RAD: Interim report January-March 2018 22
Jan 31, 2018: C-RAD AB – Consolidated Year-End report January-December 2017 23
Oct 27, 2017: C-RAD – Interim report January-September 2017 24
Corporate Communications 25
Aug 14, 2018: C-RAD has appointed Cecilia Danckwardt-Lilliestrom as new CFO 25
Legal and Regulatory 26
Jun 20, 2017: Appeal Court final resolution of dispute over C-RAD’s entitlement to patents 26
Other Significant Developments 27
Dec 13, 2017: Update on C-RAD delivery of its advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna 27
Jan 30, 2017: C-RAD and MD Anderson Cancer Center concluded agreement to supply innovative SIGRT solution 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
C-Rad AB, Medical Equipment, Key Facts, 2017 2
C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
C-Rad AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
C-Rad AB, Deals By Market, 2012 to YTD 2018 8
C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GE Healthcare Enters into Distribution Agreement with C-Rad 10
C-Rad Raises USD2.5 Million in Private Placement of Series B Shares 11
C-RAD Raises USD5.4 Million in Rights Offering of Shares 12
C-RAD to Raise USD3 Million in Rights Offering of Series B Shares 14
C-Rad Acquires Remaining 71% Stake in Cyrpa International 15
C-Rad Acquired 29% Stake In Cyrpa International, Radiotherapy Products Developer, For USD1.4 Million 17
C-Rad AB, Key Competitors 18
C-Rad AB, Key Employees 19
C-Rad AB, Subsidiaries 20

List of Figures
C-Rad AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
C-Rad AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
C-Rad AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[C-Rad AB (CRAD B):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Ipsos SA (IPS):企業の財務・戦略的SWOT分析
    Ipsos SA (IPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Xvivo Perfusion AB (XVIVO):企業の財務・戦略的SWOT分析
    Summary Xvivo Perfusion AB (Xvivo) is a medical technology company that provides organ transplantation solutions. The company develops organ preservation products such as perfadex and silicone tubing sets and normothermic perfusion products. It offers normothermic perfusion products such as STEEN so …
  • MRC Global Inc (MRC):企業の財務・戦略的SWOT分析
    MRC Global Inc (MRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Samsung Heavy Industries Co Ltd:戦略・SWOT・企業財務分析
    Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Azul SA (AZUL):企業の財務・戦略的SWOT分析
    Azul SA (AZUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Fortis Healthcare Ltd (FORTIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Fortis Healthcare Ltd (Fortis) is an integrated healthcare provider that delivers healthcare services in the Pan Asia-Pacific region. The company’s services portfolio comprises diagnostics, primary care, day care and specialty hospitals. It owns, operates, and manages a chain of multi-specia …
  • Anpario Plc (ANP):企業の財務・戦略的SWOT分析
    Summary Anpario Plc (Anpario), formerly Kiotech International Plc is a producer and distributor of natural feed additives for animal health, hygiene and nutrition. The company develops products for poultry, pig, ruminant and animal feed markets that include acidifiers, essential oils, enzymes, pelle …
  • Wincanton Plc (WIN):企業の財務・戦略的SWOT分析
    Wincanton Plc (WIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Fiat Chrysler Automobiles NV:企業のM&A・事業提携・投資動向
    Fiat Chrysler Automobiles NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fiat Chrysler Automobiles NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • BioRestorative Therapies Inc (BRTX):医療機器:M&Aディール及び事業提携情報
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Best Doctors Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Best Doctors Inc (Best Doctors), a subsidiary of Teladoc, Inc, is a healthcare service provider that offers medical services. The company provides services such as inter-consultation and critical care inter-consultation services for multi-trauma, spinal cord injuries, traumatic brain injurie …
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds onshore exploration licences in Lithuania and France. Tethys Oil holds Gargzdai license, Rietavas license and Raseiniai license …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • ORBIT Communication Systems Ltd:企業の戦略・SWOT・財務情報
    ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Easywell Biomedical Inc (1799)-医療機器分野:企業M&A・提携分析
    Summary Easywell Biomedical Inc (Easywell), formerly Actherm Inc is a health care company that offers medical devices and testing devices. The company offers pharmaceuticals, regenerative medicines and medical devices, among others. Its medical devices comprise pain management systems, non-contact, …
  • ATS Automation Tooling Systems Inc (ATA):企業の財務・戦略的SWOT分析
    ATS Automation Tooling Systems Inc (ATA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Thames Water Utilities Ltd:企業の戦略・SWOT・財務情報
    Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report Summary Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • 3D Systems Corp (DDD):企業の財務・戦略的SWOT分析
    3D Systems Corp (DDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆